Comparative Safety of Midline Catheters and PICCs in Long-term Intravenous Therapy
In a recent groundbreaking trial conducted at a Danish academic tertiary care center, researchers have shed light on the safety and efficacy of midline catheters (MCs) compared to peripherally inserted central catheters (PICCs) in adult patients requiring intravenous therapy for a duration of 5 to 28 days. The trial found that there was a low incidence of Catheter-related bloodstream infections with no significant difference between MCs and PICCs in patients receiving medium- to long-term intravenous therapy. However, the use of MCs resulted in a higher incidence of overall catheter-related complications compared with PICCs.
The trial results were published in the journal JAMA Network Open.
Midline catheters (MCs) have become a common choice in medical settings, yet a comprehensive assessment of their safety and efficacy relative to peripherally inserted central catheters (PICCs) has been lacking. This critical gap in knowledge has prompted researchers to delve into a thorough examination of the two catheter types to provide clearer insights into their comparative performance. Hence, researchers carried out a parallel, 2-group, open-label, randomized clinical trial (RCT) aimed to address the existing gap in knowledge regarding the two widely used catheter types. The study, spanning from October 2018 to February 2022, enrolled a total of 304 patients with a mean age of 64.6 years, of whom 42.8% were female. Each participant was randomly assigned to either the MC group or the PICC control group in a 1:1 ratio.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.